Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Telephone: +44 1443848585
E-mail: catherine.scully@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Stem Cell Collection Equipment, Consumables and Maintenance
Reference number: WBS/STA/739
II.1.2) Main CPV code
38434520
II.1.3) Type of contract
Supplies
II.1.4) Short description
Stem cell collection apparatus, consumables and associated maintenance to support the establishment of a new in-house NHS Stem Cell Collection Service
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
290 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
38434520
II.2.3) Place of performance
NUTS code:
UKL22
Main site or place of performance:
Velindre Cancer Centre, Velindre Road, Cardiff.
II.2.4) Description of the procurement
Purchase of 2 Apheresis Stem Cell Spectra Optia machines, plus consumables and maintenance for the equipment life. Via the publication of a Prior Information Notice 02/12/20 (PIN WA Ref: 106238), the Authority sought expressions of interest from suitable candidates to provide the Apheresis Stem Cell Collection Service to the current specification. No such expressions were received.
II.2.11) Information about options
Options:
Yes
Description of options:
Options to purchase consumables and maintenance beyond the manufacturers original asset life of 10 years.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Failure to implement the collection centre in accordance with the WBS technical requirements would result in the service being unable to provide stem cells for both Welsh and global patients, removing the contingency site for stem cell collection. New equipment requires evaluation in a live donor scenario. This would result in an extension to the validation process for an undetermined period.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Negotiated procedure without prior publication
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons
Explanation:
The Authority therefore intends to award a contract under the provisions of the Negotiated Procedure without Prior Notification (Regulation 32) to Terumo BCT for the purchase of 2 Apheresis Stem Cell Spectra Optia machines, along with the associated consumables and appropriate maintenance agreements, for the life of the equipment as recommended by the manufacturer. Changing the equipment collection system would most likely result in adjustments being required to the collection service operation model, as no two systems operate to the same specification. Subsequently this would impact upon the Service ability to collect sufficient cells within an acceptable timeframe, to meet the needs of the patient awaiting treatment e.g. more days may be required to collect the stem cells. The WBMDR collection centre provides contingency for Stem Cell Apheresis collection at the University Hospital of Wales (UHW) and vice versa. The ‘Spectra Optia’ Apheresis machines are already in situ at UHW. Purchasing different equipment would require UHW nurses to be trained in the use of the new equipment. WBMDR Nurses and those within the University Hospital of Wales (which provide continuity in case of service failure at either site), are all trained to use the Spectra Optias and have no experience of using alternative systems. Requirement to re-train on an alternative solution will result in a delay to provision of stem cells for patients. Particularly as the majority of staff at this time are diverted to supporting the NHS Wales response to the Covid-19 pandemic. The Authority needs to publish this notice in accordance with the Public Contract Regulations 2015, under Regulation 32 (Use of the negotiated procedure without prior publication), specifically: 32(1) In the specific cases and circumstances laid down in this regulation, contracting authorities may award public contracts by a negotiated procedure without prior publication. General grounds: 32(2)(b)(ii) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:— 2(b) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons:— (ii) competition is absent for technical reasons.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: WBS/STA/739
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
18/01/2021
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Terumo BCT Ltd
Old Belfast , Millbrook
Larne
BT402SH
UK
NUTS: UKN0
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
290 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=107338.
(WA Ref:107338)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
19/01/2021